ArticleCancer drug resistance (Alhambra, Calif.)2023

Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma.

Liia Akhuba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.